These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2142434)

  • 1. Adult mastocytosis: an immunophenotypic and flow-cytometric investigation.
    Ormerod AD; Herriot R; Davidson RJ; Sewell HF
    Br J Dermatol; 1990 Jun; 122(6):737-44. PubMed ID: 2142434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial mastocytosis: a clinical, immunophenotypic, light and electron microscopic study.
    Anstey A; Lowe DG; Kirby JD; Horton MA
    Br J Dermatol; 1991 Dec; 125(6):583-7. PubMed ID: 1836952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lineage commitment of HLA-DR/CD38-defined progenitor cell subpopulations in bone marrow and mobilized peripheral blood assessed by four-color immunofluorescence.
    Harvey K; Higgins N; Akard L; Chang Q; Jansen J; Thompson J; Dugan M; Rizzo MT; English D
    J Hematother; 1997 Jun; 6(3):243-52. PubMed ID: 9234179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
    Jordan JH; Walchshofer S; Jurecka W; Mosberger I; Sperr WR; Wolff K; Chott A; Bühring HJ; Lechner K; Horny HP; Valent P
    Hum Pathol; 2001 May; 32(5):545-52. PubMed ID: 11381374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of lymphocytes, granulocytes, mast cells and their related cytokines in lesional skin of linear IgA bullous dermatosis.
    Caproni M; Rolfo S; Bernacchi E; Bianchi B; Brazzini B; Fabbri P
    Br J Dermatol; 1999 Jun; 140(6):1072-8. PubMed ID: 10354073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotype of bone marrow mast cells in indolent systemic mast cell disease in adults.
    Escribano L; Díaz Agustín Beatriz ; Bravo P; Navalón R; Almeida J; Orfao A
    Leuk Lymphoma; 1999 Oct; 35(3-4):227-35. PubMed ID: 10706445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two novel mast cell phenotypic markers, monoclonal antibodies Ki-MC1 and Ki-M1P, identify distinct mast cell subtypes.
    Hamann K; Haas N; Grabbe J; Welker P; Czarnetzki BM
    Br J Dermatol; 1995 Oct; 133(4):547-52. PubMed ID: 7577581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
    Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
    J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1.
    Stemme S; Holm J; Hansson GK
    Arterioscler Thromb; 1992 Feb; 12(2):206-11. PubMed ID: 1531930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
    Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
    Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminase 2 expressed in mast cells recruited into skin or bone marrow induces the development of pediatric mastocytosis.
    Ahn YM; Hong GU; Kim SH; Lee HJ; Baek HS; Kim MN; Park KY; Ro JY
    Pediatr Allergy Immunol; 2015 Aug; 26(5):438-45. PubMed ID: 25952500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric assessment of human peripheral blood mononuclear cells in response to a coccidioidal antigen.
    Ampel NM; Christian L
    Med Mycol; 2000 Apr; 38(2):127-32. PubMed ID: 10817229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders.
    Sánchez-Muñoz L; Teodósio C; Morgado JM; Escribano L
    Methods Cell Biol; 2011; 103():333-59. PubMed ID: 21722810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
    Kestens L; Vanham G; Vereecken C; Vandenbruaene M; Vercauteren G; Colebunders RL; Gigase PL
    Clin Exp Immunol; 1994 Mar; 95(3):436-41. PubMed ID: 7907956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis.
    Núñez-López R; Escribano L; Schernthaner GH; Prados A; Rodríguez-González R; Díaz-Agustín B; López A; Hauswirth A; Valent P; Almeida J; Bravo P; Orfao A
    Br J Haematol; 2003 Jan; 120(2):257-65. PubMed ID: 12542483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease.
    Rodrigues DS; Medeiros EA; Weckx LY; Bonnez W; Salomão R; Kallas EG
    Clin Exp Immunol; 2002 Apr; 128(1):149-54. PubMed ID: 11982602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cell surface antigens on mast cells: mast cell phenotyping.
    Hauswirth AW; Florian S; Schernthaner GH; Krauth MT; Sonneck K; Sperr WR; Valent P
    Methods Mol Biol; 2006; 315():77-90. PubMed ID: 16110150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal expression of CD antigens in mastocytosis.
    Escribano L; Díaz-Agustín B; Núñez R; Prados A; Rodríguez R; Orfao A
    Int Arch Allergy Immunol; 2002 Feb; 127(2):127-32. PubMed ID: 11919422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers.
    Anand A; Dean GS; Quereshi K; Isenberg DA; Lydyard PM
    Lupus; 2002; 11(8):493-500. PubMed ID: 12220103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.